China National Accord Medicines Corp Ltd
SZSE:000028
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
24.15
40.79
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
China National Accord Medicines Corp Ltd
Free Cash Flow
China National Accord Medicines Corp Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Free Cash Flow
¥2.5B
|
CAGR 3-Years
61%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Free Cash Flow
¥16.7B
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
12%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Free Cash Flow
¥3.2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
9%
|
CAGR 10-Years
31%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Free Cash Flow
¥316.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Free Cash Flow
¥1.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
8%
|
CAGR 10-Years
22%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Free Cash Flow
¥2.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
41%
|
CAGR 10-Years
12%
|
|
China National Accord Medicines Corp Ltd
Glance View
China National Accord Medicines Corp Ltd, nestled within the bustling healthcare landscape of China, operates at the heart of the pharmaceutical distribution and retail sectors. Established with the goal of ensuring that essential medicines and healthcare services are accessible to the vast Chinese population, the company has built an extensive distribution network. This network efficiently links manufacturers with hospitals, clinics, and pharmacies, making certain that a myriad of pharmaceutical products reach their intended destinations. By leveraging a combination of logistical prowess and vast geographical coverage, the company adeptly navigates the complexities of supply chain management, underscoring its role as a critical player in China's healthcare infrastructure. Beyond distribution, China National Accord Medicines also capitalizes on the booming retail pharmaceuticals market through its chain of pharmacies. These retail outlets serve as direct points of sale to consumers, offering both prescription and over-the-counter medications, alongside health consultation services. This dual focus on both wholesale distribution and retail outlets enables the company to capture value across the supply chain, from manufacturer to end-user. The strategic alignment of its operations streamlines efficiency and generates revenue, sustaining its growth amid a fiercely competitive and rapidly evolving market. Through this integrated approach, the company solidifies its position as a crucial conduit in the delivery of healthcare solutions across China.
See Also
What is China National Accord Medicines Corp Ltd's Free Cash Flow?
Free Cash Flow
2.5B
CNY
Based on the financial report for Sep 30, 2024, China National Accord Medicines Corp Ltd's Free Cash Flow amounts to 2.5B CNY.
What is China National Accord Medicines Corp Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
10%
Over the last year, the Free Cash Flow growth was 48%. The average annual Free Cash Flow growth rates for China National Accord Medicines Corp Ltd have been 61% over the past three years , 10% over the past five years .
You don't have any saved screeners yet